Anticancer double lipid prodrugs: Liposomal preparation and characterization

Journal of Liposome Research

Volumn 21, Issue 4, 2011, Pages 296-305

  Arouri, Ahmad ^a   Mouritsen, Ole G ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Anticancer prodrug; Lipid mixture; NBDdithionite interaction; Secretory phospholipase A2 (sPLA2); Triggered drug release

Indexed keywords

ANTINEOPLASTIC AGENT; DITHIONITE; LIPID; LIPOSOME; PHOSPHOLIPID; PRODRUG; SECRETORY PHOSPHOLIPASE A2;

ARTICLE; CANCER CELL; CANCER THERAPY; CHEMICAL MODIFICATION; DIFFERENTIAL SCANNING CALORIMETRY; LIGHT SCATTERING; LIPID COMPOSITION; MEMBRANE PERMEABILITY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; UPREGULATION;

1,2-DIPALMITOYLPHOSPHATIDYLCHOLINE; ANTINEOPLASTIC AGENTS; CALORIMETRY, DIFFERENTIAL SCANNING; HUMANS; LIPIDS; LIPOSOMES; MOLECULAR STRUCTURE; PERMEABILITY; PRODRUGS; RECEPTORS, RETINOIC ACID; RETINOIDS;

EID: 80054699811     PISSN: 08982104     EISSN: 15322394     Source Type: Journal    
DOI: 10.3109/08982104.2011.563365     Document Type: Article

References (67)

1. Andresen, T. L., Davidsen, J., Begtrup, M., Mouritsen, O. G., Jorgensen, K.2004). Enzymatic release of antitumor ether lipids by specific phospholipase A2 activation of liposome-forming prodrugs. J Med Chem 47:1694-1703. (Pubitemid 38380912)
2. Andresen, T. L., Jensen, S. S., Jorgensen, K.2005a). Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release. Progr Lipid Res 44:68-97. (Pubitemid 40313220)
3. Andresen, T. L., Jensen, S. S., Kaasgaard, T., Jorgensen, K.2005b). Triggered activation and release of liposomal prodrugs and drugs in cancer tissue by secretory phospholipase A2. Curr Drug Deliv 2:353-362. (Pubitemid 41277767)
4. Andresen, T. L., Jensen, S. S., Madsen, R., Jorgensen, K.2005c). Synthesis and biological activity of anticancer ether lipids that are specifically released by phospholipase A2 in tumor tissue. J Med Chem 48:7305-7314. (Pubitemid 41743644)
5. Arouri, A., Dathe, M., Blume, A.2009). Peptide induced demixing in PG/PE lipid mixtures: a mechanism for the specificity of antimicrobial peptides towards bacterial membranes? Biochim Biophys Acta 1788:650-659.
6. Barenholz, Y.2003). Relevancy of drug loading to liposomal formulation therapeutic efficacy. J Liposome Res 13:1-8. (Pubitemid 36378121)
7. Chen, Y., Hu, L.2009). Design of anticancer prodrugs for reductive activation. Med Res Rev 29:29-64.
8. Chowdhry, B. Z., Lipka, G., Sturtevant, J. M.1984). Thermodynamics of phospholipid-sucrose interactions. Biophys J 46:419-421. (Pubitemid 14046119)
9. Christensen, M. S., Pedersen, P. J., Andresen, T. L., Madsen, R., Clausen, M. H.2010). Isomerization of all-(E)-retinoic acid mediated by carbodiimide activation-synthesis of ATRA ether lipid conjugates. Eur J Org Chem 719-724.
10. Das, M., Mohanty, C., Sahoo, S. K.2009). Ligand-based targeted therapy for cancer tissue. Exp Opin Drug Deliv 6:285-304.
11. Davidsen, J., Jorgensen, K., Andresen, T. L., Mouritsen, O. G.2003). Secreted phospholipase A2 as a new enzymatic trigger mechanism for localised liposomal drug release and absorption in diseased tissue. Biochim Biophys Acta 1609:95-101. (Pubitemid 36044070)
12. Davidsen, J., Mouritsen, O. G., Jorgensen, K.2002). Synergistic permeability enhancing effect of lysophospholipids and fatty acids on lipid membranes. Biochim Biophys Acta 1564:256-262. (Pubitemid 34717892)
13. De Carvalho, L. M., Schwedt, G.2001). Polarographic determination of dithionite and its decomposition products: kinetic aspects, stabilizers, and analytical application. Anal Chim Acta 436:293-300. (Pubitemid 32522445)
14. Gordeliy, V. I., Kiselev, M. A., Lesieur, P., Pole, A. V., Teixeira, J.1998). Lipid membrane structure and interactions in dimethyl sulfoxide/ water mixtures. Biophys J 75:2343-2351. (Pubitemid 28492117)
15. Graff, J. R., Konicek, B. W., Deddens, J. A., Chedid, M., Hurst, B. M., Colligan, B., et al.2001). Expression of group IIa secretory phospholipase A2 increases with prostate tumor grade. Clin Cancer Res 7:3857-3861. (Pubitemid 34044601)
16. Grit, M., Crommelin, D. J. A.1992). The effect of aging on the physical stability of liposome dispersions. Chem Phys Lipids 62:113-122.
17. Guler, S. D., Ghosh, D. D., Pan, J., Mathai, J. C., Zeidel, M. L., Nagle, J. F., et al.2009). Effects of ether vs. ester linkage on lipid bilayer structure and water permeability. Chem Phys Lipids 160:33-44.
18. Hanahan, D., Weinberg, R. A.2000). The hallmarks of cancer. Cell 100:57-70. (Pubitemid 30046295)
19. Hashizaki, K., Taguchi, H., Itoh, C., Sakai, H., Abe, M., Saito, Y., et al.2005). Effects of poly(ethylene glycol) (PEG) concentration on the permeability of PEG-grafted liposomes. Chem Pharm Bull 53:27-31. (Pubitemid 40879830)
20. Hata, T., Matsuki, H., Kaneshina, S.2000). Effect of local anesthetics on the phase transition temperatures of ether- and ester-linked phospholipid bilayer membranes. Coll Surf B 18:41-50. (Pubitemid 30074200)
21. Honger, T., Jorgensen, K., Biltonen, R. L., Mouritsen, O. G.1996). Systematic relationship between phospholipase A2 activity and dynamic lipid bilayer microheterogeneity. Biochemistry 35:9003-9006. (Pubitemid 26249845)
22. Hoyrup, P., Mouritsen, O. G., Jorgensen, K.2001). Phospholipase A(2) activity towards vesicles of DPPC and DMPC-DSPC containing small amounts of SMPC. Biochim Biophys Acta 1515:133-143. (Pubitemid 33086830)
23. Huang, C., Li, S.1999). Calorimetric and molecular mechanics studies of the thermotropic phase behavior of membrane phospholipids. Biochim Biophys Acta 1422:273-307. (Pubitemid 29512381)
24. Huster, D., Muller, P., Arnold, K., Herrmann, A.2001). Dynamics of membrane penetration of the fluorescent 7-nitrobenz-2- oxa-1,3-diazol-4-yl (NBD) group attached to an acyl chain of phosphatidylcholine. Biophys J 80:822-831. (Pubitemid 32128333)
25. Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Thun, M. J.2009). Cancer statistics, 2009. CA Cancer J Clin 59:225-249.
26. Jensen, S. S., Andresen, T. L., Davidsen, J., Hoyrup, P., Shnyder, S. D., Bibby, M. C., et al.2004). Secretory phospholipase A2 as a tumorspecific trigger for targeted delivery of a novel class of liposomal prodrug anticancer etherlipids. Mol Cancer Ther 3:1451-1458. (Pubitemid 39562590)
27. Jiang, J., Neubauer, B. L., Graff, J. R., Chedid, M., Thomas, J. E., Roehm, N. W., et al.2002). Expression of group IIA secretory phospholipase A2 is elevated in prostatic intraepithelial neoplasia and adenocarcinoma. Am J Pathol 160:667-671. (Pubitemid 34160344)
28. Kaasgaard, T., Andresen, T. L.2010). Liposomal cancer therapy: exploiting tumor characteristics. Exp Opin Drug Deliv 7:225-243.
29. Kashiwagi, M., Friess, H., Uhl, W., Berberat, P., Abou-Shady, M., Martignoni, M., et al.1999). Group II and IV phospholipase A2 are produced in human pancreatic cancer cells and influence prognosis. Gut 45:605-612. (Pubitemid 29447833)
30. Kennedy, B. P., Soravia, C., Moffat, J., Xia, L., Hiruki, T., Collins, S., et al.1998). Overexpression of the nonpancreatic secretory group II PLA2 messenger RNA and protein in colorectal adenomas from familial adenomatous polyposis patients. Cancer Res 58:500-503. (Pubitemid 28087413)
31. Kisak, E. T., Coldren, B., Evans, C. A., Boyer, C., Zasadzinski, J. A.2004). The vesosome-a multicompartment drug delivery vehicle. Curr Med Chem 11:199-219. (Pubitemid 38139229)
32. Kisak, E. T., Coldren, B., Zasadzinski, J. A.2002). Nanocompartments enclosing vesicles, colloids, and macromolecules via interdigitated lipid bilayers. Langmuir 18:284-288. (Pubitemid 35382307)
33. Kiyohara, H., Egami, H., Kako, H., Shibata, Y., Murata, K., Ohshima, S., et al.1993). Immunohistochemical localization of group II phospholipase A2 in human pancreatic carcinomas. Int J Pancreatol 13:49-57. (Pubitemid 23086378)
34. Klein, C. A.2009). Parallel progression of primary tumours and metastases. Nat Rev Cancer 9:302-312.
35. Kraske, W. V., Mountcastle, D. B.2001). Effects of cholesterol and temperature on the permeability of dimyristoylphosphatidylcholine bilayers near the chain melting phase transition. Biochim Biophys Acta 1514:159-164. (Pubitemid 32831004)
36. Kudo, I.2004). Diversity of phospholipase A2 enzymes. Biol Pharm Bull 27:1157.
37. Lambeau, G., Gelb, M. H.2008). Biochemistry and physiology of mammalian secreted phospholipases A2. Annu Rev Biochem 77:495-520.
38. Langner, M., Hui, S.2000). Effect of free fatty acids on the permeability of 1,2-dimyristoyl-sn-glycero-3-phosphocholine bilayer at the main phase transition. Biochim Biophys Acta 1463:439-447. (Pubitemid 30081801)
39. Langner, M., Hui, S. W.1993). Dithionite penetration through phospholipid bilayers as a measure of defects in lipid molecular packing. Chem Phys Lipids 65:23-30. (Pubitemid 23201247)
40. Laye, J. P., Gill, J. H.2003). Phospholipase A2 expression in tumours: a target for therapeutic intervention? Drug Discov Today 8:710-716. (Pubitemid 36970002)
41. Leidy, C., Linderoth, L., Andresen, T. L., Mouritsen, O. G., Jorgensen, K., Peters, G. H.2006). Domain-induced activation of human phospholipase A2 type IIA: local versus global lipid composition. Biophys J 90:3165-3175.
42. Lund, B. W., Knapp, A. E., Piu, F., Gauthier, N. K., Begtrup, M., Hacksell, U., et al.2009). Design, synthesis, and structure-activity analysis of isoform-selective retinoic acid receptor beta ligands. J Med Chem 52:1540-1545.
43. Lund, B. W., Piu, F., Gauthier, N. K., Eeg, A., Currier, E., Sherbukhin, V., et al.2005). Discovery of a potent, orally available, and isoform-selective retinoic acid beta2 receptor agonist. J Med Chem 48:7517-7519. (Pubitemid 41698794)
44. Malam, Y., Loizidou, M., Seifalian, A. M.2009). Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer. Trends Pharmacol Sci 30:592-599.
45. Matsuki, H., Miyazaki, E., Sakano, F., Tamai, N., Kaneshina, S.2007). Thermotropic and barotropic phase transitions in bilayer membranes of ether-linked phospholipids with varying alkyl chain lengths. Biochim Biophys Acta 1768:479-489. (Pubitemid 46275581)
46. Matsuki, H., Okuno, H., Sakano, F., Kusube, M., Kaneshina, S.2005). Effect of deuterium oxide on the thermodynamic quantities associated with phase transitions of phosphatidylcholine bilayer membranes. Biochim Biophys Acta 1712:92-100. (Pubitemid 40799284)
47. Matsumura, Y., Maeda, H.1986). A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 46:6387-6392. (Pubitemid 17221789)
48. Mayer, L. D., Krishna, R., Webb, M., Bally, M.2000). Designing liposomal anticancer drug formulations for specific therapeutic applications. J Liposome Res 10:99-115.
49. McIntyre, J. C., Sleight, R. G.1991). Fluorescence assay for phospholipid membrane asymmetry. Biochemistry 30:11819-11827.
50. Mills, J. K., Needham, D.2005). Lysolipid incorporation in dipalmitoylphosphatidylcholine bilayer membranes enhances the ion permeability and drug release rates at the membrane phase transition. Biochim Biophys Acta 1716:77-96. (Pubitemid 41532286)
51. Minko, T., Dharap, S. S., Pakunlu, R. I., Wang, Y.2004). Molecular targeting of drug delivery systems to cancer. Curr Drug Targ 5:389-406. (Pubitemid 38559349)
52. Mouritsen, O. G., Andresen, T. L., Halperin, A., Hansen, P. L., Jakobsen, A. F., Jensen, U. B., et al.2006). Activation of interfacial enzymes at membrane surfaces. J Phys Condens Mat 18:1293-1304.
53. Murata, K., Egami, H., Kiyohara, H., Oshima, S., Kurizaki, T., Ogawa, M.1993). Expression of group-II phospholipase A2 in malignant and non-malignant human gastric mucosa. Br J Cancer 68:103-111. (Pubitemid 23178559)
54. Papahadjopoulos, D., Moscarello, M., Eylar, E. H., Isac, T.1975). Effects of proteins on thermotropic phase transitions of phospholipid membranes. Biochim Biophys Acta 401:317-335.
55. Pedersen, P. J., Adolph, S. K., Andresen, T. L., Madsen, M. W., Madsen, R., Clausen, M. H.2010a). Prostaglandin phospholipid conjugates with unusual biophysical and cytotoxic properties. Bioorg Med Chem Lett 20:4456-4458.
56. Pedersen, P. J., Adolph, S. K., Subramanian, A. K., Arouri, A., Andresen, T. L., Mouritsen, O. G., et al.2010b). Liposomal formulation of retinoids designed for enzyme triggered release. J Med Chem 53:3782-3792.
57. Pedersen, P. J., Christensen, M. S., Ruysschaert, T., Linderoth, L., Andresen, T. L., Melander, F., et al.2009). Synthesis and biophysical characterization of chlorambucil anticancer ether lipid prodrugs. J Med Chem 52:3408-3415.
58. Provencher, S. W.1982). CONTIN: a general purpose constrained regularization program for inverting noisy linear algebraic and integral equations. Comput Phys Commun 27:229-242.
59. Risbo, J., Jorgensen, K., Sperotto, M. M., Mouritsen, O. G.1997). Phase behavior and permeability properties of phospholipid bilayers containing a short-chain phospholipid permeability enhancer. Biochim Biophys Acta 1329:85-96. (Pubitemid 27466065)
60. Ruocco, M. J., Siminovitch, D. J., Griffin, R. G.1985). Comparative study of the gel phases of ether- and ester-linked phosphatidylcholines. Biochemistry 24:2406-2411. (Pubitemid 15015743)
61. Sandstrom, M. C., Ickenstein, L. M., Mayer, L. D., Edwards, K.2005). Effects of lipid segregation and lysolipid dissociation on drug release from thermosensitive liposomes. J Contr Rel 107:131-142. (Pubitemid 41253709)
62. Silvander, M., Johnsson, M., Edwards, K.1998). Effects of PEG-lipids on permeability of phosphatidylcholine/cholesterol liposomes in buffer and in human serum. Chem Phys Lipids 97:15-26. (Pubitemid 28557010)
63. Six, D. A., Dennis, E. A.2000). The expanding superfamily of phospholipase A2 enzymes: classification and characterization. Biochim Biophys Acta 1488:1-19.
64. Stutts, K. J.1987). Liquid chromatographic assay of dithionite and thiosulfate. Anal Chem 59:543-544.
65. Tribler, L., Jensen, L. T., Jorgensen, K., Brunner, N., Gelb, M. H., Nielsen, H. J., et al.2007). Increased expression and activity of group IIA and X secretory phospholipase A2 in peritumoral versus central colon carcinoma tissue. Anticancer Res 27:3179-3185. (Pubitemid 47607540)
66. Yu, Z. W., Quinn, P. J.1995). Phase stability of phosphatidylcholines in dimethylsulfoxide solutions. Biophys J 69:1456-1463.
67. Zucker, D., Marcus, D., Barenholz, Y., Goldblum, A.2009). Liposome drugs' loading efficiency: a working model based on loading conditions and drug's physicochemical properties. J Contr Rel 139:73-80.